Percorrendo por Autor FUJIHARA, KAZUO
Mostrando regs. 1 a 7 de 7
Data de publicação | Título | Autor(es) |
2020 | CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD | KLEEREKOOPER, IRIS; HERBERT, MEGAN K; KUIPERIJ, H BEA, et al |
2023 | Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria | BANWELL, BRENDA; BENNETT, JEFFREY L; MARIGNIER, ROMAIN, et al |
2017 | MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy | OGAWA, RYO; NAKASHIMA, ICHIRO; TAKAHASHI, TOSHIYUKI, et al |
2018 | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder | DOS PASSOS, GIORDANI RODRIGUES; OLIVEIRA, LUANA MICHELLI; DA COSTA, BRUNA KLEIN, et al |
2021 | Myelin-oligodendrocyte glycoprotein antibody-associated disease | MARIGNIER, ROMAIN; HACOHEN, YAEL; COBO-CALVO, ALVARO, et al |
2016 | Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications | PASSOS, GIORDANI RODRIGUES DOS; Douglas Kazutoshi Sato; BECKER, JEFFERSON, et al |
2020 | Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients | WHITTAM, DANIEL H; COBO-CALVO, ALVARO; LOPEZ-CHIRIBOGA, A SEBASTIAN, et al |